This is in contrast to the higher expression levels (both at mRNA and protein level) of Nox5 in PCa cell lines (LNCaP and PC‐3) compared to benign cell lines (RWPE1 and EP156T) (Fig. 3). The gene discussed is NOX5; the disease is posterior cortical atrophy.